Veru (VERU)
(Delayed Data from NSDQ)
$0.77 USD
+0.02 (2.11%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.76 -0.01 (-1.29%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 20% (51 out of 252)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.60 | 1.68 | 9.99 |
Current Quarter Estimate | -0.07 | 7.52 | 63.00 |
Year Ago Quarter Estimate | -0.16 | 4.51 | 52.25 |
Next Quarter Estimate | -0.08 | 8.28 | 66.00 |
Next Year Estimate | -0.29 | 45.12 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 73.21 | 12.30 | NA |
Next Year | 3.33 | 22.60 | NA |
Last 5 Years | -239.50 | 2.90 | 8.10 |
Next 5 Years | NA | 14.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 4.37 |
Price/Book (MRQ) | 3.00 | 2.15 |
Price/Cash Flow (MRFY) | NA | 11.85 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -376.38% | -9.40% |
Return on Equity (TTM) | -115.99% | -1.06% |
Debt to Equity (MRQ) | NA | 22.25 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.